Tomita Katsuyuki, Sano Hiroyuki, Iwanaga Takashi, Ishihara Kyosuke, Ichinose Masakazu, Kawase Ichirou, Kimura Hiroshi, Hirata Kazuto, Fujimura Masaki, Mishima Michiaki, Tohda Yuji
Department of Respiratory Medicine and Allergology, Faculty of Medicine, Kinki University, Osaka, Japan.
J Asthma. 2012 Apr;49(3):253-9. doi: 10.3109/02770903.2012.661009. Epub 2012 Feb 29.
Asthma has several phenotypical features, including recurrent exacerbations and recurrent episodes of upper respiratory infection (URI).
A retrospective study was performed to identify the characteristics of adult patients with recurrent exacerbations of asthma, especially in association with recurrent episodes of URI.
Information was collected using a self-administered questionnaire given to 7070 patients in autumn-winter 2006, 4859 patients in spring-summer 2007, and 4452 patients in autumn-winter 2007. The patients reported the degree of symptoms and the frequency of febrile episodes of URI and exacerbations. Severe exacerbations were defined as a self-report of asthma-related hospitalization, an emergency department visit, or a requirement for systemic corticosteroids. Recurrent febrile URI and exacerbations were defined as two or more episodes within the previous 6 months. A Poisson regression model was used to identify the factors that were predictors of a risk for exacerbations.
Of the 6266 patients who completed the questionnaire, the frequencies of febrile URI and episodes of severe exacerbations were 1.54 and 0.54 per subject per year, respectively. Logistic regression analysis showed that an older age [odds ratio (OR): 1.57; 95% confidence interval (CI): 1.15-2.13], female sex (OR: 1.58; 95% CI: 1.20-2.08), recurrent febrile episodes of URI (OR: 2.68; 95% CI: 1.47-4.91), a history of previous exacerbation within 1 year (OR: 1.74; 95% CI: 1.28-2.34), disuse of inhaled corticosteroids (ICSs) (OR: 2.63; 95% CI: 1.68-4.12), and disuse of add-on leukotriene receptor antagonists (LTRAs) (OR: 1.42; 95% CI: 1.06-1.74) were independently associated with moderate to severe symptom-severity. Poisson regression analysis showed that the independent factors that contributed to the frequency of recurrent severe exacerbations were female sex (regression coefficient β = 0.62, p < .01), an episode of sputum with coughing (β = 1.23, p < .01), nocturnal awakening (β = 1.22, p < .01), and severe exacerbation (β = 0.78, p < .01) within the previous 6 months.
Symptom-severity of asthma and the frequency of severe exacerbations were associated with previous exacerbations and susceptibility to URI.
哮喘具有多种表型特征,包括反复加重以及上呼吸道感染(URI)反复发作。
进行一项回顾性研究,以确定哮喘反复加重的成年患者的特征,尤其是与URI反复发作相关的特征。
通过在2006年秋冬向7070例患者、2007年春夏向4859例患者以及2007年秋冬向4452例患者发放的自填式问卷收集信息。患者报告症状程度以及URI发热发作和哮喘加重的频率。严重加重定义为自我报告的与哮喘相关的住院、急诊就诊或全身用糖皮质激素治疗需求。反复发热性URI和加重定义为过去6个月内发作两次或更多次。使用泊松回归模型确定加重风险的预测因素。
在完成问卷的6266例患者中,发热性URI和严重加重发作的频率分别为每年每位患者1.54次和0.54次。逻辑回归分析显示,年龄较大[比值比(OR):1.57;95%置信区间(CI):1.15 - 2.13]、女性(OR:1.58;95%CI:1.20 - 2.08)、URI反复发热发作(OR:2.68;95%CI:1.47 - 4.91)、1年内既往有加重史(OR:1.74;95%CI:1.28 - 2.34)、未使用吸入性糖皮质激素(ICS)(OR:2.63;95%CI:1.68 - 4.12)以及未使用附加白三烯受体拮抗剂(LTRA)(OR:1.42;95%CI:1.06 - 1.74)与中度至重度症状严重程度独立相关。泊松回归分析显示,导致反复严重加重频率的独立因素为女性(回归系数β = 0.62,p <.01)、咳嗽伴咳痰发作(β = 1.23,p <.01)、夜间觉醒(β = 1.22,p <.01)以及过去6个月内严重加重(β = 0.78,p <.01)。
哮喘的症状严重程度和严重加重频率与既往加重以及对URI的易感性相关。